Reports for BAUSCH HEALTH, CANADA INC.
Company Name
BAUSCH HEALTH, CANADA INC.
Totals |
||
Shortage reports |
387 |
|
| Actual shortage: | 12 (3%) | |
| Anticipated shortage: | 3 (1%) | |
| Avoided shortage: | 37 (10%) | |
| Resolved: | 335 (87%) | |
Discontinuation Reports |
19 |
|
| To be discontinued: | 0 (0%) | |
| Discontinued: | 19 (100%) | |
| Reversed: | 0 (0%) | |
Late reports |
101 (25%) |
|
Overdue reports |
10 (67%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ROFACT | 300MG | CAPSULE | Resolved | 2024-03-18 | 2024-04-17 | 222584 |
| ROFACT | 150MG | CAPSULE | Resolved | 2019-09-06 | 2020-03-18 | 93236 |
| ROFACT | 150MG | CAPSULE | Avoided shortage | 2020-04-09 | 2020-04-23 | 111785 |
| ROFACT | 150MG | CAPSULE | Resolved | 2020-06-03 | 2020-07-27 | 116496 |
| ROFACT | 150MG | CAPSULE | Resolved | 2022-12-07 | 2023-02-24 | 177254 |
| ROFACT | 150MG | CAPSULE | Avoided shortage | 2023-04-28 | 2023-05-31 | 191061 |
| ROFACT | 150MG | CAPSULE | Resolved | 2017-03-17 | 2017-06-16 | 3290 |
| ROFACT | 150MG | CAPSULE | Resolved | 2017-05-26 | 2017-06-16 | 11360 |
| ROFACT | 300MG | CAPSULE | Resolved | 2017-03-13 | 2017-04-12 | 1621 |
| ROFACT | 300MG | CAPSULE | Avoided shortage | 2018-05-11 | 2018-07-09 | 49062 |
| ROFACT | 300MG | CAPSULE | Resolved | 2018-10-29 | 2019-08-01 | 65751 |
| SUBLINOX | 10MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2017-10-02 | 2017-11-13 | 24049 |
| SUBLINOX | 10MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2018-03-02 | 2018-06-20 | 41546 |
| SUBLINOX | 10MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2021-06-02 | 2021-11-30 | 140229 |
| SUBLINOX | 10MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2024-05-31 | 2024-09-11 | 229320 |
| SUBLINOX | 5MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2018-03-02 | 2018-06-30 | 41543 |
| SUBLINOX | 5MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2019-06-12 | 2019-07-05 | 86505 |
| SUBLINOX | 5MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2019-10-10 | 2019-10-17 | 96014 |
| SUBLINOX | 5MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2021-10-05 | 2021-12-09 | 146697 |
| SUBLINOX | 5MG | TABLET (ORALLY DISINTEGRATING) | Avoided shortage | 2024-09-25 | 2024-10-03 | 238527 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| AIROMIR | 100MCG | METERED-DOSE AEROSOL | Discontinued | 2023-11-29 | 2023-11-29 | 211859 |
| ALTACE HCT | 12.5MG 2.5MG | TABLET | Discontinued | 2023-12-21 | 2024-01-09 | 214011 |
| ALTACE HCT | 12.5MG 5MG | TABLET | Discontinued | 2023-12-21 | 2024-01-09 | 214014 |
| ALTACE HCT | 25MG 5MG | TABLET | Discontinued | 2023-12-21 | 2024-01-09 | 214017 |
| ALTACE HCT | 12.5MG 10MG | TABLET | Discontinued | 2023-12-21 | 2024-01-09 | 214024 |
| ALTACE HCT | 25MG 10MG | TABLET | Discontinued | 2023-12-21 | 2024-01-09 | 214027 |
| CARBOLITH | 600MG | CAPSULE | Discontinued | 2025-01-10 | 2025-01-10 | 247420 |
| CARBOLITH | 150MG | CAPSULE | Discontinued | 2025-01-10 | 2025-01-23 | 247417 |
| CARBOLITH | 300MG | CAPSULE | Discontinued | 2025-01-09 | 2025-01-09 | 247352 |
| CARBOLITH | 300MG | CAPSULE | Discontinued | 2025-01-09 | 2025-01-09 | 247345 |
| DELATESTRYL | 200MG | SOLUTION | Discontinued | 2024-03-11 | 2024-04-26 | 221772 |
| LIDEX | 0.05% | CREAM | Discontinued | 2023-12-08 | 2023-12-08 | 212804 |
| LODALIS | 3.75G | POWDER FOR SUSPENSION | Discontinued | 2023-12-08 | 2025-04-15 | 212799 |
| MANERIX | 150MG | TABLET | Discontinued | 2025-01-07 | 2025-01-08 | 246998 |
| MANERIX | 300MG | TABLET | Discontinued | 2025-01-07 | 2025-01-08 | 247005 |
| THEOLAIR | 80MG | SOLUTION | Discontinued | 2021-04-26 | 2021-04-27 | 138081 |
| VITAMIN A ACID | 0.05% | GEL | Discontinued | 2024-01-30 | 2024-02-08 | 217843 |
| VITAMIN A ACID | 0.025% | GEL | Discontinued | 2024-01-30 | 2024-02-08 | 217848 |
| VITAMIN A ACID | 0.01% | GEL | Discontinued | 2024-01-30 | 2024-05-23 | 217835 |
Showing 1 to 19 of 19